JNJ-64400141

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameJNJ-64400141
Drug Alias NameRSV Senior prophylactic vaccineRSV Jr prophylactic vaccineAd26.RSV.preFAd26-RSV-preFVAC-18194 +[7] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLower Respiratory Tract InfectionsRespiratory Tract DiseasesRespiratory Syncytial Virus Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncJanssen Vaccines & Prevention Bv
Inactive CompaniesJohnson & Johnson (China) Investment LtdJanssen Vaccines CorpCatalent Pharma Solutions +[7] 
Active IndicationsLower Respiratory Tract InfectionsRespiratory Syncytial Virus InfectionsInfluenza, Human
Inactive IndicationsRespiratory Tract DiseasesRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A